FDAnews Device Daily Bulletin

EUROCOR GMBH RECEIVES CE MARK APPROVAL FOR TAXCOR I

July 11, 2006
A A

Eurocor Gmbh an Opto Circuits company has received CE mark approval of its new polymer-free, TAXCOR I.Paclitaxel-eluting coronary stent system. Though polymer-free, this innovative drug-eluting stent technology eliminates any polymer-related, late adverse effect potential for the patient, like subacute thrombosis.
My Iris